Endocrinology, Vol 119, 1768-1775, Copyright © 1986 by Endocrine Society

ARTICLES

A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution

DE Ingber, JA Madri and J Folkman

A new class of angiostatic steroids acts independently of previously identified steroid functions to inhibit angiogenesis when administered with heparin. Development of angiostatic steroids as therapeutic modulators of blood vessel growth would be greatly facilitated if their mode of action were thoroughly understood. However, the mechanism by which these steroids produce capillary regression is not known. The distributions of fibronectin and laminin were studied in growing and regressing capillaries by immunofluorescence microscopy to determine whether capillary basement membrane (BM) alterations could be involved in the mechanism of antiangiogenesis. In normal 8-day-old chick chorioallantoic membrane, fibronectin and laminin appeared in continuous linear patterns within BM surrounding growing capillaries. In contrast, chorioallantoic membranes treated with combinations of angiostatic steroid and heparin exhibited capillary BM fragmentation and eventually complete loss of fibronectin and laminin from regions of capillary involution. Capillary BM breakdown correlated with capillary retraction, endothelial cell rounding, and associated capillary regression. BM surrounding large vessels, neighboring epithelium, and nongrowing capillaries were not affected. Capillary BM dissolution is the first biochemical action identified for this new class of antiangiogenic steroids.

This article has been cited by other articles:

				G. J. Ryan New pharmacologic approachesto treating diabetic retinopathy Am. J. Health Syst. Pharm., September 1, 2007; 64(17_Supplement_12): S15 - S21. [Abstract] [Full Text] [PDF]

				J. G. Arroyo A 76-year-old man with macular degeneration. JAMA, May 24, 2006; 295(20): 2394 - 2406. [Full Text] [PDF]

				D. Rekow Informatics Challenges in Tissue Engineering and Biomaterials Adv. Dent. Res., December 1, 2003; 17(1): 49 - 54. [Abstract] [Full Text] [PDF]

				P. Baluk, S. Morikawa, A. Haskell, M. Mancuso, and D. M. McDonald Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors Am. J. Pathol., November 1, 2003; 163(5): 1801 - 1815. [Abstract] [Full Text] [PDF]

				B. Annabi, Y.-T. Lee, S. Turcotte, E. Naud, R. R. Desrosiers, M. Champagne, N. Eliopoulos, J. Galipeau, and R. Beliveau Hypoxia Promotes Murine Bone-Marrow-Derived Stromal Cell Migration and Tube Formation Stem Cells, May 1, 2003; 21(3): 337 - 347. [Abstract] [Full Text] [PDF]

				D. E. Ingber Mechanical Signaling and the Cellular Response to Extracellular Matrix in Angiogenesis and Cardiovascular Physiology Circ. Res., November 15, 2002; 91(10): 877 - 887. [Abstract] [Full Text] [PDF]

				J. S. Penn, V. S. Rajaratnam, R. J. Collier, and A. F. Clark The Effect of an Angiostatic Steroid on Neovascularization in a Rat Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 283 - 290. [Abstract] [Full Text]

				L Yan, M. Moses, S Huang, and D. Ingber Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells J. Cell Sci., January 11, 2000; 113(22): 3979 - 3987. [Abstract] [PDF]

				J. H. Schiller and G. Bittner Potentiation of Platinum Antitumor Effects in Human Lung Tumor Xenografts by the Angiogenesis Inhibitor Squalamine: Effects on Tumor Neovascularization Clin. Cancer Res., December 1, 1999; 5(12): 4287 - 4294. [Abstract] [Full Text] [PDF]

				T Korff and H. Augustin Tensional forces in fibrillar extracellular matrices control directional capillary sprouting J. Cell Sci., January 10, 1999; 112(19): 3249 - 3258. [Abstract] [PDF]

				S. Huang, C. S. Chen, and D. E. Ingber Control of Cyclin D1, p27Kip1, and Cell Cycle Progression in Human Capillary Endothelial Cells by Cell Shape and Cytoskeletal Tension Mol. Biol. Cell, November 1, 1998; 9(11): 3179 - 3193. [Abstract] [Full Text]

				J. M. Rosenstein, N. Mani, W. F. Silverman, and J. M. Krum Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo PNAS, June 9, 1998; 95(12): 7086 - 7091. [Abstract] [Full Text] [PDF]

				M. Rusnati, E. Tanghetti, P. Dell'Era, A. Gualandris, and M. Presta alpha vbeta 3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells Mol. Biol. Cell, December 1, 1997; 8(12): 2449 - 2461. [Abstract] [Full Text]

				C. S. Chen, M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber Geometric Control of Cell Life and Death Science, May 30, 1997; 276(5317): 1425 - 1428. [Abstract] [Full Text]

				M. A. Moses The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors Stem Cells, May 1, 1997; 15(3): 180 - 189. [Abstract] [Full Text]

				N. Klauber, F. Browne, B. Anand-Apte, and R. J. D'Amato New Activity of Spironolactone: Inhibition of Angiogenesis In Vitro and In Vivo Circulation, November 15, 1996; 94(10): 2566 - 2571. [Abstract] [Full Text]

				R. M. Strieter, P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis J. Biol. Chem., November 10, 1995; 270(45): 27348 - 27357. [Abstract] [Full Text] [PDF]

				L. Seymour Review : Synthetic Polymers with Intrinsic Anticancer Activity Journal of Bioactive and Compatible Polymers, January 1, 1991; 6(2): 178 - 216. [PDF]

				J Folkman, P. Weisz, M. Joullie, W. Li, and W. Ewing Control of angiogenesis with synthetic heparin substitutes Science, March 17, 1989; 243(4897): 1490 - 1493. [Abstract] [PDF]

				J Folkman and M Klagsbrun Angiogenic factors Science, January 23, 1987; 235(4787): 442 - 447. [Abstract] [PDF]